Hepatic levels of mRNA specific for total serum amyloid A (SAA), the SAA1 and SAA2 isotypes, serum amyloid P (SAP), C-reactive protein (CRP), and fibronectin, as well as the plasma concentrations of SAA and SAP were examined in amyloid-resistant (A/J) and amyloid-susceptible (CBA/J) mice during azocaseininduced chronic inflammation. In both strains hepatic SAA and SAP mRNA levels and plasma SAA and SAP protein concentrations increased dramatically during the early stages of inflammation; this was followed by a decrease to concentrations that were maintained at levels considerably higher than background. The ratios of SAA1 and SAA2 mRNA and plasma protein were 1 ∶ 1 throughout. This indicated that there was no preferential accumulation of mRNA specifying a particular isotype and no preferential synthesis or clearance of a particular isotype during chronic inflammation and the early stages of amyloidogenesis in either strain. Similarly, hepatic SAP mRNA levels in both strains increased dramatically during the early stages of inflammation and were subsequently maintained at elevated levels. Plasma SAP concentrations increased rapidly during the first three days of the study in both A/J and CBA/J mice; however, during the later stages of inflammation, A/J plasma SAP levels decreased to a steady-state concentration that was approximately half that observed in CBA/J mice. Our results identify differences in the hepatic mRNA and plasma protein levels of the major mouse acute-phase reactants (APR) in the amyloid-resistant A/J and amyloid-susceptible CBA/J mouse strains. These findings are consistent with circulating inflammatory APR concentrations contributing, together with other factors, to the onset and pathogenesis of secondary amyloidosis.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Kushner, I. 1982. The phenomenon of the acute phase response.Ann. N.Y. Acad. Sci. 389:39.
Sipe, J. D., K. P. W. J. McAdam, andF. Uchino. 1978. Biochemical evidence for the biphasic development of experimental amyloidosis.Lab. Invest. 38:110.
Cohen, A. S., andE. Calkins. 1959. Electron microscopic observation on a fibrous component in amyloid of diverse origins.Nature 183:1202.
Husebekk, A., B. Skogen, G. Husby, andG. Marhaug. 1985. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrilsin vivo.Scand. J. Immunol. 21:283.
Pepys, M. B., R. F. Dyck, F. C. Debeer, M. Skinner, andA. S. Cohen. 1979. Binding of serum amyloid P component (SAP) by amyloid fibrils.Clin. Exp. Immunol. 38:248.
Benditt, E. P., andN. Eriksen. 1977. Amyloid protein SAA is associated with high density lipoprotein from human serum.Proc. Natl. Acad. Sci. U.S.A. 74:4025.
Meek, R. L., andE. P. Benditt. 1986. Amyloid A gene family expression in different mouse tissues.J. Exp. Med. 164:2006.
Lowell, C. A., D. A. Potter, R. S. Stearman, andJ. F. Morrow. 1986. Structure of the murine amyloid A gene family.J. Biol. Chem. 261:8442.
Yamamoto, K. I., M. Shiroo, andS. Migita. 1986. Diverse gene expression for isotypes of murine serum amyloid A protein during acute phase reaction.Science 232:227.
Meek, R. L., J. S. Hoffman, andE. P. Benditt. 1986. Amyloidogenesis: One serum amyloid A isotype is selectively removed from the circulation.J. Exp. Med. 163:499.
Shiroo, M., E. Kawahara, I. Nakanishi, andS. Migata. 1987. Specific deposition of serum amyloid protein 2 in the mouse.Scand. J. Immunol. 26:709.
Osmand, A. P., B. Friedenson, H. Gewurz, R. H. Painter, T. Hoffman, andE. Shelton. 1977. The characterization of C-reactive protein and C1t as pentraxins: Homologous proteins displaying cyclic pentameric symmetry.Proc. Natl. Acad. Sci. U.S.A. 74:739.
Pepys, M. B., M. L. Baltz, K. Gomer, A. J. S. Davis, andM. Doenhoff. 1979. Serum amyloid P-component is an acute phase reactant in mouse.Nature 278:259.
Zahedi, K., andA. S. Whitehead. 1989. Acute phase induction of mouse serum amyloid P component. Correlation with other parameters of inflammation.J. Immunol. 143:2880.
Mortensen, R. F., K. Beisel, N. J. Zeleznik, andP. T. Le. 1983. Acute phase reactants of mice: II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation.J. Immunol. 130:885.
Cohen, A. S., andE. S. Cathcart. 1972. Casein-induced experimental amyloidosis. 1. Review of cellular and immunological aspects.Methods Achiev. Exp. Pathol. 6:207.
Wohlgethan J. R., andE. S. Cathcart. 1979. Amyloid resistance in A/J mice is determined by a single gene.Nature 278:453.
Janigan, D. T., andR. L. Druet. 1968. Experimental amyloidosis. Role of antigenicity and rapid induction.Am. J. Pathol. 48:1013.
Axelsen, N. H., and P. J.Svendsen. 1973. Reversed rocket immunoelectrophoresis. In A Manual of Quantitative Immunoelectrophoresis.Scand. J. Immunol. Vol. 2, Suppl. 1. N. H. Axelsen, J. Kroll, and B. Weeke, editors. 155.
Sipe, J. D., T. F. Ignaczak, P. S. Pollock, andG. G. Glenner, 1976. Amyloid fibril protein AA: Purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay.J. Immunol. 116:1151.
Sipe, J. D., W. A. Gonnerman, L. D. Loose, G. Knapschaefer, W. J. Xie, andC. Franzblau. 1989. Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA).J. Immunol. Methods 125:125.
Strachan, A. F., W. F. Brandt, P. Woo, D. R. Van Der Westhuyzen, G. A. Coetzee, M. C. Debeer, E. G. Shephard, andF. C. Debeer. 1989. Human serum amyloid A protein. The assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci.J. Biol. Chem. 264:18368.
Strachan A. F., F. C. Debeer, D. R. Van Der Westhuyzen, andG. A. Coetzee. 1988. Identification of three isoform patterns of human serum amyloid A protein.Biochem. J. 250:203.
Puchtler, H., E. Sweat, andM. Levin. 1964. On the binding of Congo red by amyloid.J. Histochem. Cytochem. 10:355.
Auffray, C., andF. Rougeon. 1980. Purification of mouse immunoglobulin heavy chain mRNA from total myeloma tumor RNA.Eur. J. Biochem. 107:303.
Whitehead, A. S., M. Rits, andJ. Michaelson. 1988. Molecular genetics of mouse serum amyloid P-component (SAP): Cloning and gene mapping. Immunogenetics28:388.
Whitehead, A. S., K. Zahedi, M. Rits, R. F. Mortensen, andJ. M. Lelias. 1990. Mouse C-reactive protein: Generation of complementary DNA clones, structural analysis, and induction of mRNA during inflammation.Biochem. J. 266:238.
Blatti, S. P., D. N. Foster, G. Ranganathan, H. L. Moses, andM. J. Getz. 1988. Induction of fibronectin gene transcription and mRNA is a primary response to growth factor stimulation of AKR.2B cells.Proc. Natl. Acad. Sci. U.S.A. 85:1119.
Sipe, J. D., H. R. Colten, G. Goldberger, M. D. Edge, B. F. Tack, A. S. Cohen, andA. S. Whitehead. 1985. Human serum amyloid A (SAA): Biosynthesis and post-synthetic processing of pre SAA and structural variants defined by complementary DNA.Biochemistry 24:2931.
Kawahara, E., M. Shiroo, I. Nakanishi, andS. Migita. 1989. The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical co-distribution and binding property with serum amyloid protein A.Am. J. Pathol. 134:1305.
Yamada, K. M. 1982. Isolation of fibronectin from plasma and cells.In Immunochemistry of the Extracellular Matrix, Vol. 1. H. Furthmayr, editor. CRC Press, Boca Raton, Florida. 111–123.
Yamada, K. M., andJ. Olden. 1978. Fibronectins-adhesive glycoproteins cell surface and blood.Nature 227:680.
DeBeer, F. C., M. L. Baltz, S. Holford, A. Feinstein, andM. B. Pepys. 1981. Fibronectin and C4 binding protein are selectively bound by aggregated amyloid P-component.J. Exp. Med. 154:1134.
Tseng, J., andR. F. Mortensen. 1987. Binding specificity of mouse serum amyloid P-component for fibronectin.Immun. Invest. 15:749.
Hebert, L., andF. Gervais. 1990. Apo-SAAl/apo-SAA2 isotype ratios during casein- and amyloid-enhancing-factor-induced secondary amyloidosis in A/J and C57BL/6 mice.Scand. J. Immunol. 31:167.
Pepys, M. B., R. F. Dyck, F. C. Debeer, M. Skinner, andA. S. Cohen. 1979. Binding of serum amyloid P-component (SAP) by amyloid fibrils.Clin. Exp. Immunol. 38:284.
Baltz, M. L., D. Caspi, D. J. Evans, I. F. Rowe, C. R. K. Hind, andM. B. Pepys. 1986. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.Clin. Exp. Immunol. 66:691.
Hawkins, P. N., M. J. Myers, A. A. Epenetos, D. Caspi, andM. B. Pepys. 1988. Specific localization and imaging of amyloid deposits in vivo using123I-Labelled serum amyloid P component.J. Exp. Med. 167:903.
Baltz, M. B., K. Gomer, A. J. S. Davies, G. G. B. Klaus, andM. B. Pepys. 1980. Differences in the acute phase response of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and resistant mouse strains.Clin. Exp. Immunol. 39:355.154:1134.
Kisilevsky, R., andL. Boudreau. 1983. Kinetics of amyloid deposition. 1. The effects of amyloid enhancing factor and splenectomy.Lab. Invest. 48:53.
Abankwa, G. V., andZ. Ali-Khan. 1988. Alveolar hydatid cyst induced amyloid enhancing factor (AEF): Physicochemical properties and abolition of AEF by serine protease inhibitors.Br. J. Exp. Pathol. 69:123.
About this article
Cite this article
Zahedi, K., Gonnerman, W.A., Debeer, F.C. et al. Major acute-phase reactant synthesis during chronic inflammation in amyloid-susceptible and -resistant mouse strains. Inflammation 15, 1–14 (1991). https://doi.org/10.1007/BF00917905
- Plasma Protein
- Chronic Inflammation
- Mouse Strain
- Reactant Synthesis